Margaret Carpenter, based in New Paltz, New York, has been indicted for prescribing abortion pills to a person in Louisiana — ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Sufficient scientific evidence exists to recommend HPV DNA testing in the triage of women with equivocal cytology and in follow-up after the treatment of precursor lesions. However, due to a low ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

A new cervical cancer treatment is showing promise in boosting survival rates and reducing recurrence What this breakthrough means for patients.

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Cervical cancer, caused by Human Papilloma Virus (HPV), is not hereditary, and HPV infection doesn't always lead to cancer. Pap smears are crucial for early detection, and HPV vaccines can prevent ...

Hong Kong has seen a 30 per cent increase in new cervical cancer cases over the past decade, reversing a downtrend since the ...

The incurable bone marrow cancer multiple myeloma often develops unnoticed in the bone marrow over decades. In advanced stages, lesions form that can destroy the bone and spread to other parts of ...

Researchers led by the Africa Centers for Disease Control (Africa CDC) will establish three Centers of Excellence in Rwanda, Morocco, and Zambia to gather evidence and accelerate efforts to end ...